genXone S.A. (WSE:GX1)
Poland · Delayed Price · Currency is PLN 5.58
0.00 (0.00%)
Last updated: Sep 9, 2025, 9:24 AM CET
genXone Revenue
genXone had revenue of 490.19K PLN in the quarter ending June 30, 2025, with 28.63% growth. This brings the company's revenue in the last twelve months to 2.00M, up 22.88% year-over-year. In the year 2024, genXone had annual revenue of 1.79M, down -25.33%.
Revenue (ttm)
2.00M
Revenue Growth
+22.88%
P/S Ratio
9.32
Revenue / Employee
125.02K
Employees
16
Market Cap
18.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.79M | -606.63K | -25.33% |
| Dec 31, 2023 | 2.39M | -8.19M | -77.38% |
| Dec 31, 2022 | 10.59M | -12.61M | -54.36% |
| Dec 31, 2021 | 23.20M | 2.72M | 13.29% |
| Dec 31, 2020 | 20.47M | 20.27M | 9,907.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.17B |
| NEUCA | 13.04B |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 560.38M |
| Celon Pharma | 215.11M |
| Ryvu Therapeutics | 97.57M |
| Selvita | 359.79M |
| Centrum Medyczne ENEL-MED | 762.83M |